Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
4
×
indiana top stories
ipo
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
texas blog main
texas top stories
vc
4
×
venture capital
wisconsin blog main
wisconsin top stories
biogen
celgene
fda
gene editing
novartis
biomarin pharmaceutical
cancer
car-t
commissioner
crispr
What
bio
roundup
ipo
new
activity
allogene
approvals
becker
billions
biogen
biopharma
cancer
car
celgene
clamped
colleagues
covid
crispr
delays
developing
diversity
dollars
eaton
economic
exome
fast
fda
gene
government
health
healthcare
hot
hundreds
immunotherapy
impact
including
industry
investors
isn’t
juno
Language
unset
Current search:
ipo
×
vc
×
" seattle blog main "
×
" indiana blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More